Japanese health authorities approved the drug to treat breast cancer, was manufactured in Switzerland, according to Reuters. The drug is intended for the treatment of HER2-positive breast cancer. This disease affects approximately 20-30 percent of women with breast cancer, the most common disease among women worldwide. Diagnosed with breast cancer more than 1 million women worldwide each year, and about 400 thousand women die each year from the disease, according to doctors. Herceptin - developed a drug to block HER2 - a protein that promotes the development of cancer, will be released in the Japanese market.
No comments:
Post a Comment